Table 1.

Ability of hemopoietic cytokines to replace M-CSF in the induction of osteoclastic differentiation

PreincubationCombinations of cytokines with RANKLTRAP-positive cells/coverslip
GM-CSF (5 ng/mL) GM-CSF (50 ng/mL) 0  
IL-3 (1 ng/mL) IL-3 (1 ng/mL) 0  
IL-3 (1 ng/mL) IL-3 (1 ng/mL) + GM-CSF (50 ng/mL) 0  
SCF (5 ng/mL) SCF (100 ng/mL) 0  
SCF (5 ng/mL) SCF (100 ng/mL) + FL (100 ng/mL) 18 ± 7  
SCF (5 ng/mL) SCF (100 ng/mL) + VEGF (100 ng/mL) 0  
FL (5 ng/mL) FL (100 ng/mL) 39 ± 14  
FL (5 ng/mL) FL (100 ng/mL) + SCF (100 ng/mL) 43 ± 23  
FL (5 ng/mL) FL (100 ng/mL) + IL-3 (1 ng/mL) 31 ± 12  
FL (5 ng/mL) FL (100 ng/mL) + VEGF (100 ng/mL) 41 ± 14 
PreincubationCombinations of cytokines with RANKLTRAP-positive cells/coverslip
GM-CSF (5 ng/mL) GM-CSF (50 ng/mL) 0  
IL-3 (1 ng/mL) IL-3 (1 ng/mL) 0  
IL-3 (1 ng/mL) IL-3 (1 ng/mL) + GM-CSF (50 ng/mL) 0  
SCF (5 ng/mL) SCF (100 ng/mL) 0  
SCF (5 ng/mL) SCF (100 ng/mL) + FL (100 ng/mL) 18 ± 7  
SCF (5 ng/mL) SCF (100 ng/mL) + VEGF (100 ng/mL) 0  
FL (5 ng/mL) FL (100 ng/mL) 39 ± 14  
FL (5 ng/mL) FL (100 ng/mL) + SCF (100 ng/mL) 43 ± 23  
FL (5 ng/mL) FL (100 ng/mL) + IL-3 (1 ng/mL) 31 ± 12  
FL (5 ng/mL) FL (100 ng/mL) + VEGF (100 ng/mL) 41 ± 14 

Bone marrow cells were preincubated for 24 hours to remove stromal cells. Normally during this phase, the survival of osteoclastic precursors is supported by M-CSF, which was replaced in these experiments by a variety of cytokines. After 24 hours, nonadherent cells were removed, washed, and resuspended in the cytokines shown, together with RANKL (30 ng/mL). TRAP-positive cells were enumerated after 6 days of incubation and expressed as mean ± SEM (6 cultures per variable).

Close Modal

or Create an Account

Close Modal
Close Modal